Furthermore, validation of the assay demonstrated linearity, as well as recoveries, of within 15% of expected values spanning the assays range, demonstrating the effectiveness of the SDS protocol to disrupt the IGF-1/IGFBP complex
Convenient capsule form Easy to incorporate into your daily routine
Dosing protocol unless otherwise specified by your doctor is 0.2 ml sub-Q (300mcg) at bedtime five nights a week
It binds the ghrelin / growth-hormone secretagogue receptor (GHS-R1a) on the pituitary, mimicking the natural hormone ghrelin and triggering a short, pulsatile release of growth hormone [1] [2]
always verify current program costs on the official ReadyRx website before enrollment
Human Evidence: Extrapolated, Not Direct No published randomized controlled trial has tested the ipamorelin-plus-CJC-1295 combination in humans